Cargando…

Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms

BACKGROUND: Bleeding assessment is part of the diagnostic workup of von Willebrand disease (VWD). Bleeding assessment tools (BATs) have standardized obtaining this information but have been criticized because they are time consuming. OBJECTIVE: To use our legacy data to determine which questions fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Spradbrow, Jordan, Letourneau, Sasha, Grabell, Julie, Liang, Yupu, Riddel, James, Hopman, Wilma, Blanchette, Victor S., Rand, Margaret L., Coller, Barry S., Paterson, Andrew D., James, Paula D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971303/
https://www.ncbi.nlm.nih.gov/pubmed/31989089
http://dx.doi.org/10.1002/rth2.12256
_version_ 1783489697348059136
author Spradbrow, Jordan
Letourneau, Sasha
Grabell, Julie
Liang, Yupu
Riddel, James
Hopman, Wilma
Blanchette, Victor S.
Rand, Margaret L.
Coller, Barry S.
Paterson, Andrew D.
James, Paula D.
author_facet Spradbrow, Jordan
Letourneau, Sasha
Grabell, Julie
Liang, Yupu
Riddel, James
Hopman, Wilma
Blanchette, Victor S.
Rand, Margaret L.
Coller, Barry S.
Paterson, Andrew D.
James, Paula D.
author_sort Spradbrow, Jordan
collection PubMed
description BACKGROUND: Bleeding assessment is part of the diagnostic workup of von Willebrand disease (VWD). Bleeding assessment tools (BATs) have standardized obtaining this information but have been criticized because they are time consuming. OBJECTIVE: To use our legacy data to determine which questions from BATs are the strongest predictors of a VWD diagnosis. PATIENTS/METHODS: Bleeding score data from 3 different BATs were used. Patients aged <12 years were excluded. Questions on BATs relate to different bleeding symptoms, and each symptom is scored by severity. Scores for each symptom were sorted based on whether they indicated clinically significant bleeding, and nonsignificant scores were set as the reference category. Multivariable logistic regression was used to determine the symptoms that were the strongest predictors of a laboratory‐confirmed VWD diagnosis. RESULTS: A total of 927 participants were included; 144 (16%) were patients with VWD, and 783 (84%) were healthy controls. The top 3 symptoms for which a clinically significant positive response increased the likelihood of VWD were hemarthrosis (odds ratio [OR], 19.2; 95% confidence interval [CI], 3.7‐100.4), postsurgical bleeding (OR, 15.2; 95% CI, 5.9‐38.9), and menorrhagia (OR, 10.3; 95% CI, 4.9‐21.9). With each increase in number of bleeding symptom categories with clinically significant scores, subjects had a stepwise increase in odds of a VWD diagnosis. CONCLUSIONS: Our results suggest that most of the bleeding symptoms on BATs are significant predictors of VWD, and there is value in assessing multiple bleeding symptoms when eliciting a bleeding history. Certain bleeding symptoms are more useful predictors than others. Future BAT revisions may consider adding a relative weighting to each symptom.
format Online
Article
Text
id pubmed-6971303
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69713032020-01-27 Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms Spradbrow, Jordan Letourneau, Sasha Grabell, Julie Liang, Yupu Riddel, James Hopman, Wilma Blanchette, Victor S. Rand, Margaret L. Coller, Barry S. Paterson, Andrew D. James, Paula D. Res Pract Thromb Haemost Original Articles: Hemostasis BACKGROUND: Bleeding assessment is part of the diagnostic workup of von Willebrand disease (VWD). Bleeding assessment tools (BATs) have standardized obtaining this information but have been criticized because they are time consuming. OBJECTIVE: To use our legacy data to determine which questions from BATs are the strongest predictors of a VWD diagnosis. PATIENTS/METHODS: Bleeding score data from 3 different BATs were used. Patients aged <12 years were excluded. Questions on BATs relate to different bleeding symptoms, and each symptom is scored by severity. Scores for each symptom were sorted based on whether they indicated clinically significant bleeding, and nonsignificant scores were set as the reference category. Multivariable logistic regression was used to determine the symptoms that were the strongest predictors of a laboratory‐confirmed VWD diagnosis. RESULTS: A total of 927 participants were included; 144 (16%) were patients with VWD, and 783 (84%) were healthy controls. The top 3 symptoms for which a clinically significant positive response increased the likelihood of VWD were hemarthrosis (odds ratio [OR], 19.2; 95% confidence interval [CI], 3.7‐100.4), postsurgical bleeding (OR, 15.2; 95% CI, 5.9‐38.9), and menorrhagia (OR, 10.3; 95% CI, 4.9‐21.9). With each increase in number of bleeding symptom categories with clinically significant scores, subjects had a stepwise increase in odds of a VWD diagnosis. CONCLUSIONS: Our results suggest that most of the bleeding symptoms on BATs are significant predictors of VWD, and there is value in assessing multiple bleeding symptoms when eliciting a bleeding history. Certain bleeding symptoms are more useful predictors than others. Future BAT revisions may consider adding a relative weighting to each symptom. John Wiley and Sons Inc. 2019-10-30 /pmc/articles/PMC6971303/ /pubmed/31989089 http://dx.doi.org/10.1002/rth2.12256 Text en © 2019 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles: Hemostasis
Spradbrow, Jordan
Letourneau, Sasha
Grabell, Julie
Liang, Yupu
Riddel, James
Hopman, Wilma
Blanchette, Victor S.
Rand, Margaret L.
Coller, Barry S.
Paterson, Andrew D.
James, Paula D.
Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title_full Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title_fullStr Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title_full_unstemmed Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title_short Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms
title_sort bleeding assessment tools to predict von willebrand disease: utility of individual bleeding symptoms
topic Original Articles: Hemostasis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971303/
https://www.ncbi.nlm.nih.gov/pubmed/31989089
http://dx.doi.org/10.1002/rth2.12256
work_keys_str_mv AT spradbrowjordan bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT letourneausasha bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT grabelljulie bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT liangyupu bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT riddeljames bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT hopmanwilma bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT blanchettevictors bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT randmargaretl bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT collerbarrys bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT patersonandrewd bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms
AT jamespaulad bleedingassessmenttoolstopredictvonwillebranddiseaseutilityofindividualbleedingsymptoms